Results 281 to 290 of about 105,968 (369)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial

Obesity, Volume 34, Issue 1, Page 58-64, January 2026.
ABSTRACT Objective This study aimed to apply The Lancet Diabetes & Endocrinology criteria for diagnosing obesity among clinical trial participants and understand participants' characteristics by obesity status. Methods The criteria were operationalized and applied to baseline data from the Long‐term Effectiveness of the Anti‐obesity medication ...
Faith Anne N. Heeren, Kathleen R. Ruddiman, Courtney Simmons, Brian N. White, Byron C. Jaeger, Nicholas M. Pajewski, Stephanie A. Hooker, Deborah B. Horn, Katy Martin‐Fernandez, Kimberly A. Gudzune, Caroline Blackwell Young, Jamy Ard, Kristina Henderson Lewis   +12 more
wiley   +1 more source

The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women. [PDF]

Front Endocrinol (Lausanne)
Sulu C, Pervaz I, Gurer T, Yildiz D, Tas A, Demir AN, Sahin S, Ozkaya HM, Konukoglu D, Tuten A, Damci T, Kelestimur F, Gonen MS.   +12 more
europepmc   +1 more source

The cost-effectiveness of subcutaneous semaglutide 2.4 mg in the management of people living with obesity and prediabetes in England

Mafalda Ramos, Sára Larsen, Francesco Fusco, Mark Lamotte, Matthew Capehorn   +4 more
openalex   +1 more source

Emulating a Randomized Controlled Trial of Long‐Acting Insulins and Cardiovascular Events Using Real‐World Data for Patients With Type 2 Diabetes

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Aims Randomized controlled trials (RCTs) have high internal validity but often have limited generalizability. To our knowledge, there have been no previous studies emulating RCTs using real‐world data to evaluate the risk of major adverse cardiovascular events (MACE) among patients with type 2 diabetes mellitus (T2DM) treated with long‐acting ...
Wanning Wang, Pauline Reynier, Michael Webster‐Clark, Oriana H. Y. Yu, Vanessa Brunetti, Kristian B. Filion   +5 more
wiley   +1 more source

Optimizing Maternal Microbiome: Role in Improved Conception and Pregnancy Outcome

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
Maternal microbiome optimization: Minimized risk and simple corrective steps. ABSTRACT Purpose To evaluate the role of optimizing the maternal microbiome in improving pregnancy outcomes, focusing on preconception and early gestation, and to propose practical diagnostic and preventive strategies, particularly in low‐ and middle‐income countries (LMIC ...
Eytan R. Barnea, Amala Nazareth, Chittaranjan N. Purandare, Anderson Pinheiro‐Borovac, Ruth Dolmo Carluccio, Nikhil C. Purandare, Fionnuala M. McAuliffe, FIGO Reproductive Endocrinology and Infertility Committee Members   +7 more
wiley   +1 more source

Undiagnosed Diabetes and Prediabetes in Yemen: A Growing Public Health Crisis in the Shadow of Conflict. [PDF]

Medicina (Kaunas)
Al-Hetar MAMY, Saud Gany SL, Rusli N, Kamaruzzaman MA, Wan Ngah WZ, Shah SA, Almatary A, A Wahab N.   +7 more
europepmc   +1 more source

Prevalence and Characteristics of Women With Polycystic Ovary Syndrome and Isolated Diagnostic Feature: A Nationwide Cross‐Sectional Survey

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose This cross‐sectional survey aimed to determine the prevalence and characteristics of polycystic ovary syndrome (PCOS) and its isolated diagnostic features among Bangladeshi women aged 10–45 years, utilizing the 2023 International Evidence‐Based Guidelines, incorporating anti‐Mullerian hormone (AMH).
Md Shahed‐Morshed, Mashfiqul Hasan, Tania Tofail, Hurjahan Banu, Nusrat Sultana, Samirah Binte Iliyas, Munira Afroz Siddika, Md. Rafayel Islam, Hafsa Mahrukh, Tahmina Ferdousi, Indira Roy, Yasmin Aktar, Hilary Yasmin, Farhana Rahman, Nazia Akter, Abdullah Al Noman‐Bhuiyan, Krishna Airi, Rifat Hossain Ratul, Prodipta Chowdhury, Koushik Ashraf, Md Rayhan Ali Mollah, Muhammad Abul Hasanat   +21 more
wiley   +1 more source

Liver fibrosis assessed via noninvasive liver fibrosis scores is associated with atherosclerotic cardiovascular disease in middle-aged and older patients with prediabetes. [PDF]

Front Endocrinol (Lausanne)
Huang Y, Yuan Y, Wu H, Zhou Z, Li L, Huang X, Xin L, Li J, Zhang J, Liu C, Zhu Q.   +10 more
europepmc   +1 more source

A double‐blind study on ulotaront's impact on weight‐related parameters in schizophrenia patients with metabolic syndrome and prediabetes: Part II

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 94-102, January 2026.
Abstract Aims Antipsychotics increase metabolic syndrome (MetSyn) and diabetes risk. Preclinical and translational research data suggest that ulotaront, an investigational trace amine‐associated receptor 1 (TAAR1) agonist, may have beneficial metabolic effects.
Snezana Milanovic, Robert Lew, Kuangnan Xiong, Emily Casavant, Gerard Galluppi, Yu‐Luan Chen, Yongquan Lai, Manu Chakravarthy, Clay Dehn, Edward Jackson, Kenneth Koblan, Seth C. Hopkins   +11 more
wiley   +1 more source

The Differential Effects of Vitamin K Across Glycaemic Outcomes in Prediabetes and Type 2 Diabetes Mellitus. [PDF]

Nutrients
Ahmed SR, Mokgalaboni K, Phoswa WN.
europepmc   +1 more source